 Photochemotherapy interferon treatment cutaneous T-cell lymphoma Eighty-two patients mycosis fungoides MF parapsoriasis plaques psoralens light PUVA Clinical histologic parameters period months years Complete clinical clearing lesions patients limited-plaque MF group parapsoriasis plaque mean total dose PUVA complete clearing early MF patients additional PUVA Patients early stages disease clear months first course PUVA Post-treatment skin biopsies early MF histologic clearing new combination therapy MF patients Recombinant interferon Roferon-A PUVA phase trial Interferon doses units times Disease stages I-B IV-B Complete responses patients partial responses patients overall response rate median duration response months range months patients therapy dose-limiting toxicities constitutional symptoms fevers malaise mental status changes depression confusion photosensitivity Interferon PUVA effective regimens treatment patients cutaneous T-cell lymphomas